Prescribing beta-blockers to patients after acute myocardial infarction

In the treatment of patients with acute coronary syndrome in the pre-reperfusion era, one of the first-line drugs was beta-blockers. Now the management strategy of such patients has changed significantly. The results of these studies confirm the important role of beta-blockers in the therapy of patients who have undergone ACS in the era of reperfusion therapy. Beta-blocker therapy may be beneficial because of a potential reduction in the risk of all-cause death. The choice of vasodilatory drugs can provide benefits and additionally prevent the occurrence of complications.